Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

FASEB J

Division of Hematology/Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Published: January 2013

Inactivation of the tumor suppressor Ras-association domain family 1 isoform A (RASSF1A) due to epigenetic silencing occurs in a variety of human cancers, and still largely unknown are the regulators and mechanisms underlying RASSF1A gene promoter methylation. Herein, we report that this methylation is regulated by p53 and death-associated protein 6 (DAXX) in acute lymphoblastic leukemia (ALL). We found that p53 bound to the RASSF1A promoter, recruiting DAXX as well as DNA methyltransferase 1 (DNMT1) for DNA methylation, which subsequently resulted in inactivation of RASSF1A in wild-type p53 ALL cells. Although the presence of p53 was required for the recruitment of DAXX and DNMT1 to the RASSF1A promoter, fluctuation in p53 protein levels did not affect the rates of RASSF1A methylation. Conversely, methylation of RASSF1A promoter was critically controlled by DAXX, as the enforced overexpression of DAXX led to enhanced RASSF1A promoter methylation, whereas inhibition of DAXX reduced RASSF1A methylation. Interestingly, we found that the p53/DAXX-mediated RASSF1A methylation regulated murine double minute 2 (MDM2) protein stability in ALL. Our results reveal a novel function for p53 in the methylation of RASSF1A promoter by its interaction with DAXX. Discovery of this mechanism provides new insight into the interactions among the tumor-related factors p53, RASSF1A, DAXX, and MDM2 in cancer pathogenesis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528318PMC
http://dx.doi.org/10.1096/fj.12-215491DOI Listing

Publication Analysis

Top Keywords

rassf1a promoter
20
methylation rassf1a
12
rassf1a
12
rassf1a methylation
12
methylation
10
daxx
9
rassf1a gene
8
gene promoter
8
p53
8
regulated p53
8

Similar Publications

Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma.

Kidney Int

December 2024

Clinic of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Comprehensive Cancer Center Freiburg (CCCF), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site, Freiburg; Signalling Research Centres BIOSS and CIBSS, Faculty of Biology University of Freiburg, Freiburg, Germany. Electronic address:

RASSF1A is frequently biallelically inactivated in clear cell renal cell carcinoma (ccRCC) due to loss of chromosome 3p and promoter hypermethylation. Here we investigated the cellular and molecular consequences of single and combined deletion of the Rassf1a and Vhl tumor suppressor genes to model the common ccRCC genotype of combined loss of function of RASSF1A and VHL. In mouse embryonic fibroblasts and in primary kidney epithelial cells, double deletion of Rassf1a and Vhl caused chromosomal segregation defects and increased formation of micronuclei, demonstrating that pVHL and RASSF1A function to maintain genomic integrity.

View Article and Find Full Text PDF
Article Synopsis
  • Aberrant epigenetic changes, specifically in DNA methylation and non-coding RNAs, play a significant role in the development of parathyroid tumors, particularly concerning the genes RASSF1A and APC, which are often downregulated in cancers.
  • In a study of parathyroid adenomas and carcinomas, RASSF1A promoter methylation was found in approximately 90% of adenomas and was inversely related to tumor size; however, APC methylation appeared less frequently.
  • The research concluded that the methylation of RASSF1A and APC is a common feature in parathyroid tumors, with the activity of DNA methyltransferases affecting
View Article and Find Full Text PDF
Article Synopsis
  • Endometrial cancer (EC) is increasingly common and linked to risk factors like obesity and estrogen exposure, creating a need for non-invasive early diagnosis.
  • Recent research highlights the potential of DNA methylation as a biomarker for detecting early-stage EC using minimally invasive samples such as urine and cervical scrapes.
  • DNA methylation markers show high diagnostic accuracy, potentially transforming clinical practice by facilitating early detection and personalized treatment plans for endometrial cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Triplex DNA formation is a promising technique for targeting genes, but has limitations in its original forming sequences.
  • Researchers developed a new molecule, guanidino-dN, which effectively recognizes methylated CG base pairs, allowing for enhanced triplex DNA formation.
  • This method successfully increased the expression of the RASSF1A gene in breast cancer cells, leading to suppressed cell growth and changes in gene expression related to cancer survival and apoptosis.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of hypermethylation of tumor suppressor genes located on chromosome 3p in the development of nasopharyngeal carcinoma (NPC), aiming to identify potential diagnostic biomarkers.
  • Using biopsy samples and healthy specimens, it was found that a significant percentage of NPC tumors exhibited hypermethylation in several candidate genes, indicating an increased risk of cancer with an association between methylation status and NPC.
  • The findings suggest that the methylation of these genes could effectively differentiate nasopharyngeal carcinoma from healthy tissues, particularly in advanced stages, making it a promising tool for diagnosis and monitoring of the disease.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!